ArticleBMC nephrology2023

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.

Djalila Mekahli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.